Kathryn Kersey
- Hepatology top 1%
- Hepatitis C virus research 24
- Liver Disease and Transplantation 4
- Gastroenterology top 2%
- Gastrointestinal motility and disorders 6
- Gastroesophageal reflux and treatments 4
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 18
- Hepatitis B Virus Studies 15
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 10
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Rosemary J. MackayBenedetta MassettoDeyuan JiangSteven KnoxEvguenia S. SvarovskaiaArmand AbergelTarik AsselahDiana M. Brainard
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Blood (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Kathryn Kersey
52 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 97
- Hepatology 911
- Gastroenterology 191
- Epidemiology 941
- Infectious Diseases 150
- Pharmacology 44
Countries citing papers authored by Kathryn Kersey
This map shows the geographic impact of Kathryn Kersey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Kersey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Kersey more than expected).
Fields of papers citing papers by Kathryn Kersey
This network shows the impact of papers produced by Kathryn Kersey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Kersey. The network helps show where Kathryn Kersey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kathryn Kersey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 16 | |
| 3 | Safety and efficacy of remdesivir in a pediatric covid-19 population | 2021 | 3 |
| 4 | 2020 | 42 | |
| 5 | 2020 | 7 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 71 | |
| 8 | 2019 | 67 | |
| 9 | 2018 | 15 | |
| 10 | 2018 | 34 | |
| 11 | 2016 | 65 | |
| 12 | 2015 | 114 | |
| 13 | 2014 | 122 | |
| 14 | 2011 | 36 | |
| 15 | 2010 | 86 | |
| 16 | Preclinical safety profile of tanespimycin (KOS-953) - a heat shock protein 90 (Hsp90) inhibitor | 2007 | 1 |
| 17 | 2005 | 20 | |
| 18 | 2004 | 12 | |
| 19 | 1996 | 10 | |
| 20 | 1993 | 1 |
About Kathryn Kersey
Kathryn Kersey is a scholar working on Hepatology, Gastroenterology and Infectious Diseases, having authored 55 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (24 papers), Liver Disease Diagnosis and Treatment (18 papers), Hepatitis B Virus Studies (15 papers), HIV/AIDS drug development and treatment (10 papers), Gastrointestinal motility and disorders (6 papers), Gastroesophageal reflux and treatments (4 papers), Liver Disease and Transplantation (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Hepatology (911 citations), Gastroenterology (191 citations) and Epidemiology (941 citations). Kathryn Kersey has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Rosemary J. Mackay, Benedetta Massetto, Deyuan Jiang, Steven Knox, Evguenia S. Svarovskaia, Armand Abergel, Tarik Asselah, Diana M. Brainard, Alison L. Hannah and Phillip S. Pang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.